Upcoming Events

  • July 28, 2014

    arrow-rightMicro- And Nanotechnologies for Medicine: Emerging Frontiers and Applications

    Time: 08:00 AM - 09:00 AM

    Location: MIT

    Register by July 15, 2014

    The advances in micro- and nanotechnologies are expected to open up new possibilities and applications in diagnostics, therapy, drug delivery, and regenerative medicine. In this workshop, participants will acquire the fundamentals and advances in the field of bioMEMs, biomaterials, and tissue engineering. Leading experts will present the latest advances in the development of novel micro- and nanotechnologies and address a range of different challenges that are of importance to biomedicine at the interface of engineering, medicine, and biological sciences. July 28-August 1 at MIT. Please view website for details and register by July 15.

  • July 29, 2014

    arrow-rightSingle-Asset vs. Platform Deals: Optionality & Value Considerations

    Time: 08:00 AM - 10:00 AM

    Location: MassBio, 300 Technology Square, eighth floor, Cambridge, MA

    How does one choose between having a monogamous relationship with one partner on a broad platform versus doing single-asset deals with multiple partners? A panel of local business development experts who will weigh on this topic from both a pharma and venture capital perspective. July 29, 8:00-10:00am, MassBio, 300 Technology Square, eighth floor, Cambridge, MA. Registration is required.

  • August 1, 2014

    arrow-rightEvergrande Center Symposium: Immunity and Inflammation in Disease and Tissue

    Time: 09:00 AM - 12:30 PM

    Location: Joseph B. Martin Conference, HMS

    Evergrande Center Symposium: Immunity and Inflammation in Disease and Tissue – August 1, 2014
    The Evergrande Center for Immunologic Diseases at Harvard Medical School and Brigham & Women’s Hospital seeks to advance biomedical research and education with a focus on understanding the basis and role of inflammation in multiple human diseases. Speakers for the first Evergrande Center Symposium on immunity and inflammation in health and disease are: Diane Mathis, Harvard Medical School; Ruslan Medzhitov, Yale University; Fiona Powrie, University of Oxford; Larry Steinman, Stanford University; and Bruce Walker, Ragon Institute. August 1, 9:00am-12:30pm, Joseph B. Martin Conference Center, Boston, MA. Please see the
    website for more information.

  • August 7, 2014

    arrow-rightUnderstanding Risk-Based Monitoring – Pros, Cons, & the Bottom Line

    Time: 08:00 AM - 10:00 AM

    Location: MassBio, 300 Technology Square, eighth floor, Cambridge, MA

    The FDA has joined the growing consensus in the pharmaceutical industry that risk-based approaches to monitoring will help ensure subject protection and overall study quality. Please join us to explore the implications and future of risk-based monitoring to your clinical programs. August 7, 8:00-10:00am, MassBio, 300 Technology Square, eighth floor, Cambridge, MA. Registration is required.

  • September 18, 2014

    arrow-rightConference: Post-Trial Responsibilities: Ethics and Implementation

    Time: 07:30 AM - 5:30 PM

    Location: Harvard Law School, Wasserstein, Cambridge, MA

    Conference: Post-Trial Responsibilities: Ethics and Implementation – September 18, 2014
    Law, policy, and guidance are vague, sometimes conflicting, and generally lacking in concrete solutions for questions regarding post-trial responsibilities. The issues are complex and demand thoughtful discourse to move the clinical trial enterprise toward meaningful solutions. The conference will include a diverse set of global stakeholders who will address and develop some consensus around various topics, such as the range of perspectives on post-trial access, implications of the 2013 Declaration of Helsinki revisions, and potential scenarios and solutions for post-trial access to medicines. September 18, 7:30am-5:30pm, Harvard Law School, Wasserstein, Cambridge, MA. For more information and to register, please visit the website.